You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

August 7, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

FDA approves empagliflozin tablets for type 2 diabetes

FDA gives the green light to Jardiance as an adjunct to diet and exercise to improve glycemic control, or blood glucose levels.
» More on the latest diabetes drug approval

New AAP guidance for RSV drug spurs manufacturer reaction

AAP’s new recommendations for RSV drug Synagis in infants fuels concern from manufacturer, AstraZeneca. » How did AZ respond?

EDITOR'S PICK

[BLOG]: The compounding challenge: A solution for all sides

Pricing changes and questionable marketing practices from some irresponsible pharmacies in the sector have led to compounding becoming somewhat of a "dirty word" among both payers and the general public.
» Full article

Continuing Education

MTM essentials for antiplatelet therapy in cardiovascular disease

This month's article is the sixth in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the pharmacokinetic and pharmacodynamic differences, clinical indications, and pertinent drug-drug interactions for antiplatelet agents in cardiovascular disease.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exam and earn up to 2 CPE credits, click here to log in with the session code 14DT08-KTF27.


Announcement: Starting this month, our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

 

Related Articles

Drug Overview: Farxiga (dapagliflozin)

Pfizer keen on acquiring AstraZeneca

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group